Phibro Animal Health (PAHC) vs Syndax Pharmaceuticals (SNDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Syndax Pharmaceuticals (SNDX) has outperformed Phibro Animal Health (PAHC) over the past year, gaining 2.4% versus a gain of 0.8%. Over five years, PAHC leads with a +71.6% price change compared with -9.1% for SNDX. Phibro Animal Health is the larger company by market cap ($1.52 billion vs $1.51 billion), about 1.0 times the size, while Syndax Pharmaceuticals is growing revenue faster (+627.8% vs +17.1%).
Phibro Animal Health pays a dividend yielding 1.28%, while Syndax Pharmaceuticals does not currently pay one. Phibro Animal Health converts more of its revenue into profit, with a net margin of 6.6% versus -165.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PAHC | SNDX |
|---|---|---|
| Share price | $37.40 | $16.90 |
| Market cap | $1.52B | $1.51B |
| 1-day change | -0.85% | -0.76% |
| YTD return | +0.11% | -19.56% |
| 1-year return | +0.78% | +2.42% |
| 5-year return | +71.56% | -9.09% |
| P/E ratio (TTM) | 15.39 | — |
| Forward P/E | 9.73 | — |
| EPS (TTM) | $2.43 | $-2.52 |
| Dividend yield | 1.28% | 0.00% |
| Annual dividend | $0.48 | $0.00 |
| Revenue (latest FY) | $1.52B | $172.35M |
| Revenue growth (YoY) | +17.12% | +627.84% |
| Net income (latest FY) | $99.72M | $-285.42M |
| Gross margin | 33.76% | — |
| Operating margin | 12.81% | -158.45% |
| Net margin | 6.57% | -165.60% |
| 52-week high | $60.08 | $25.59 |
| 52-week low | $28.25 | $12.99 |
| Distance from 52-week high | -37.75% | -33.96% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +17.65% | +122.19% |
| Average volume | 236.19K | 1.55M |
| Shares outstanding | 21.11M | 89.30M |
| Employees | 2,605 | 298 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Phibro Animal Health offers a meaningfully higher dividend yield (1.28% vs 0.00%).
- Phibro Animal Health is more profitable, keeping 6.6 cents of every revenue dollar as net income versus -165.6 cents for Syndax Pharmaceuticals.
- Syndax Pharmaceuticals grew revenue faster in its latest fiscal year (+627.84% vs +17.12%).
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
About Syndax Pharmaceuticals
SNDX stock →Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease.
Health Care · Biotechnology: Pharmaceutical Preparations · 298 employees
PAHC vs SNDX FAQ
Which is bigger, Phibro Animal Health or Syndax Pharmaceuticals?
Phibro Animal Health (PAHC) is larger, with a market capitalization of $1.52B compared with $1.51B for Syndax Pharmaceuticals (SNDX).
Which stock has performed better over the past year, PAHC or SNDX?
SNDX returned +2.42% over the past 12 months, compared with +0.78% for PAHC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Phibro Animal Health or Syndax Pharmaceuticals?
Phibro Animal Health pays a dividend yielding 1.28%, while Syndax Pharmaceuticals does not currently pay a regular dividend.
Are Phibro Animal Health and Syndax Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.